Background: Health care costs are generally highest in the year before death, and much attention has been directed toward reducing costs for end-of-life care. However, it is unknown whether cardiovascular risk profile earlier in life influences health care costs in the last year of life. This study addresses this question.
H
EALTH CARE COSTS ARE generally highest at the end of life; a disproportionately large percentage of all Medicare expenditures is for the year prior to death. [1] [2] [3] While decedents comprise approximately 5% of all Medicare beneficiaries, expenses in the last year of life account for up to 31% of total Medicare expenditures. [1] [2] [3] Moreover, each year cardiovascular disease (CVD) accounts for almost 39% of all deaths in the United States. 4 With the proportion of Americans 65 years and older increasing rapidly, Medicare spending at the end of life is an important issue.
Much attention has been directed toward reducing costs for end-of-life care, [5] [6] [7] [8] but little research has focused on identifying factors related to lower health care utilization as a means of cost containment. It has been shown that the benefits of having favorable levels of all major CVD risk factors (ie, low risk in young adulthood and middle age) encompass not only lower age-specific risk of mortality 9, 10 but also favorable economic impact on average annual Medicare charges. 11 However, previous studies on health care costs incurred at the end of life are limited mostly to the effects of sociodemographic factors. 3, [12] [13] [14] To our knowledge, no data exist on whether the benefits of low CVD risk profile at younger ages extend to lower Medicare expenditures in the last year of life, reflecting lower disease and disability even in the period before death. We address this question with data from the Chicago Heart Association Detection Project in Industry (CHA) study on men and women aged 32 to 64 years at baseline in 1967 through 1973, who died at ages 66 to 99 years and had Medicare coverage for at least 1 year in 1984 through 2002.
METHODS

BASELINE EXAMINATION AND MORTALITY FOLLOW-UP
During 1967 through 1973, the CHA study screened 39 522 men and women 18 years or older employed by 84 Chicago-area organizations. Standardized methods were used. 15 Briefly, trained staff measured height, weight, supine blood pressure, and serum cholesterol. 16 Participants completed a questionnaire about demographic characteristics, smoking history, medical diagnoses, and treatment. Resting electrocardiograms (ECGs) were classified as showing major, minor, or no abnormalities. 17, 18 With use of data from the National Death Index, 19 vital status was ascertained through 2002 (average, 32 years follow-up). The study protocol has received periodic institutional review board approval. Appropriate administrative and physical safeguards were established to protect confidentiality of the data.
MEDICARE CHARGES DATA
Medicare fee-for-service claims data were obtained from the Centers for Medicare and Medicaid Services for participants aged 65 and older who were eligible for Medicare benefits from 1984 (the first year data were available for research use) through 2002. Centers for Medicare and Medicaid Services data for each participant were cross-referenced by social security number, sex, and birth date. Records include-for each medical service billed to Medicare-date of service, total charges, diagnostic-related group, primary diagnosis, and up to 9 other diagnoses coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Claims related to inpatient, skilled nursing facility, and outpatient hospitalrelated care were available for 1984 through 2002; physician visit claims (part B), durable medical equipment, home health agency, and hospice claims for 1992 through 2002.
ELIGIBILITY AND STUDY COHORT
Persons with a history of myocardial infarction and major ECG abnormality at baseline were excluded because data from these individuals could not only skew costs but also obscure the relationship of baseline risk profile with subsequent CVDrelated expenditures. Among 23 926 participants aged 32 to 64 years at baseline, free of myocardial infarction and major ECG abnormalities, 9860 deaths occurred through 2002. Of these, 6921 decedents aged 66 to 99 years with at least 1 full year of Medicare coverage during 1984 through 2002 were eligible for this study. Of these decedents, 383 were excluded owing to missing data on risk factors and other variables used in the models. One decedent with total charges exceeding $2 million (almost double the next highest amount-clearly an outlier) was also excluded. Thus, the study cohort includes 6582 decedents (40.4% women).
CARDIOVASCULAR RISK GROUPS
Participants were classified according to baseline CVD risk status as low risk, that is, having favorable levels of all major risk factors: blood pressure 120/80 mm Hg or lower and not receiving antihypertensive medication, 20 serum cholesterol level lower than 200 mg/dL (Ͻ5.2 mmol/L), 21 body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters) lower than 25.0, 22 not currently smoking, no diagnosed diabetes, and no minor ECG abnormalities.
9-11 Individuals not at low risk were grouped as having any 1 only, any 2 only, any 3 only, or 4 or more of the risk factors unfavorable, that is, blood pressure higher than 120/80 mm Hg or receiving antihypertensive medication, serum cholesterol level 200 mg/dL or higher (Ն5.2 mmol/L) or receiving cholesterol-lowering medication, BMI 25.0 or greater, currently smoking, diagnosed diabetes, and presence of minor ECG abnormalities.
STATISTICAL ANALYSIS
Medicare claims were used to estimate health care spending. For each beneficiary, hospital-related charges (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) or charges from all types of services covered by Medicare (1992 Medicare ( -2002 in the 1-year period before date of death were summed. Charges related to CVD were defined as those for health care services with primary discharge diagnosis coded as ICD-9-CM 390 through 459.
Baseline characteristics were compared across risk groups. Either 2 (for categorical variables) or F tests (for continuous variables) were used to detect statistically significant differences. Mean CVD-related and total charges in the year before death were computed for each risk stratum by the general linear model method, with adjustment for sex, race, education, and age at death because Medicare expenditures in the last year of life tend to be lower at older ages. 12, 13 Given the skewed nature of charge data, a modified Cox regression procedure 11 was used to assess statistical significance. This approach assumes a semiparametric model for associations of medical costs with cardiovascular risk strata and other factors. In this approach, health care charges are first inverted by subtracting each person's charge from the maximal charge. Inverted charges are then substituted for survival time in the Cox model so that people with the highest charges are treated as having the shortest survival times and those with no charges are considered censored at the maximal charge (equivalent to the longest survival time). With this method linear trends across risk factor groups are assessed using an ordinal variable with values 1 to 5 in Cox regressions.
To account for inflation, all charges were adjusted to year 2002 dollars with use of the hospital and related services component of the Consumer Price Index. 23 This correction also helps to control for changes in costs stemming from advances in medical technology over time. To estimate costs, annual cost-tocharge ratios for hospital patient care services obtained from the Medicare Payment Advisory Commission were applied to each year's Medicare charges. 24 Cost-charge ratios from 1984 through 2002 ranged from 0.800 to 0.413. Sensitivity analyses substituting estimated costs for charges were conducted. In addition, analyses were performed excluding beneficiaries enrolled in managed care plans.
Analyses were also repeated for the subsample of decedents (n=4876) with data on charges from all types of claims (1992-2002) and for subcohorts of decedents without minor ECG abnormalities and diabetes at baseline (n=5827 with hospital-related charges; n=4378 with charges for all types of services). All analyses were conducted using SAS statistical software version 8.02 (SAS Institute Inc, Cary, NC).
RESULTS
BASELINE CHARACTERISTICS
By definition, risk groups differed in average blood pressure, serum cholesterol level, BMI, and prevalence of smoking, diabetes, and minor ECG abnormalities ( Table 1) . Low-risk decedents were also younger and more educated.
AGE AT DEATH AND MEDICARE CHARGES
On average, persons with 4 or more risk factors died at a younger age compared with others ( Table 2) . Average health care charges for inpatient and outpatient care in the last year of life were lowest for low-risk individuals compared with persons with unfavorable levels of any 1 or more risk factors (Table 2 ). For example, CVD and total charges for low-risk individuals were less by $10 367 and $15 318 compared with those with 4 or more risk factors; the fewer the unfavorable risk factors, the lower the Medicare charges (P for trends Ͻ.001). Results for men and women separately were consistent with those for the total sample; P for trends ranged from .009 to Ͻ.001 (Figure) .
For the subcohort with charge data on all types of services covered by Medicare (n=4876), patterns of associations were generally similar, that is, lower CVD and total average Medicare charges in the last year of life for lowrisk persons compared with others ( Table 3) . For example, CVD-related and total charges for low-risk decedents were lower by $14 684 and $8868 compared with those with 4 or more risk factors (P for trends Ͻ.001 and .01, respectively). Analyses by sex using charge data on all types of services showed similar patterns (data not shown). Exclusion of beneficiaries enrolled in managed care plans (ranging from 1.7% in 1991 to 7.4% in 2002) had little impact on the observed relationship of risk status with Medicare charges (P for trends ranged from .03 to Ͻ.001).
With dollar amounts lower for estimated Medicare costs, differences in health care costs across risk groups were similar to those with Medicare charges. For example, adjusted total average annual costs for low-risk persons and those with 4 or more risk factors were $23 235 and $34 453, a relative difference of 48.3%, similar to that seen with charges (35.8%) (data not shown). For decedents without minor ECG abnormalities and diabetes at baseline, favorable levels of all 4 cardiovascular risk factors (serum cholesterol, blood pressure, BMI, and no smoking) were also associated with lower Medicare charges in the last year of life compared with those with unfavorable levels of these risk factors (P for trends Ͻ.004) (data not shown).
Charges in the last year of life for hospital inpatient and outpatient care ( Table 4 ) and for all types of services covered by Medicare ( Table 5) were stratified by sex, age at death, race, and education. In concordance with published data, 1, 3 Medicare expenditures in the last year of life were generally lower for CHA participants who died after age 75 years 1 compared with younger decedents (ie, age Ͻ70-74 years) and higher among blacks. 3 
COMMENT
Among both men and women, we found a significant graded positive association between cardiovascular risk profile in young adulthood or middle age and CVD-related and total Medicare charges in the last year of life. In general, cardiovascular and total end-of-life health care expenditures for hospital-related services were lowest for low-risk persons and increased with number of unfavorable risk factors. Similar results were observed in analyses by sex and for expenditures from all types of Medicare-covered services.
High health care costs incurred by persons at the end of life have generated concern as an important contributor to rising medical expenditures by older persons, 25, 26 and almost one third of Medicare costs is incurred in the last year of life. [1] [2] [3] With most persons-including those at high risk for CVD-surviving past age 65 years, 27 and the projected increase in the proportion of the population 65 years and older from 12% in 2000 to 20% by 2050, 28 absolute number of deaths in older persons and total dollars spent on care at the end of life are bound to increase, with important implications for future Medicare expenditures.
Approaches to control costs at the end of life have included use of advanced directives and establishment of hospital guidelines to identify and reduce unnecessary care. [5] [6] [7] [8] However, some argue that cost savings from such health care practices are unlikely to be substantial, for example, an estimated 6% for Medicare and 3% for total health care spending at the end of life. 29 Major cardiovascular risk factors measured in young adulthood and middle age strongly predict cardiovascular and allcause mortality long-term. 9, 10 In addition, CVD risk profile at younger ages predicts morbidity and healthrelated quality of life in older age. 30, 31 Furthermore, both cumulative disability and disability in the 1 to 2 years before death are lower in persons previously with low or moderate risk (based on levels of smoking, BMI, and exercise) compared with high-risk individuals. 32, 33 Unfortunately, low-risk individuals comprised only a small minority (Ͻ10%) of the CHA population at baseline. Low-risk status was similarly rare in the National Health and Nutrition Examination Surveys (NHANES) and continues to be uncommon among adult Americans. Data from NHANES for US adults aged 18 to 79 years, with low-risk defined as BP lower than 120/80 mm Hg, cholesterol level lower than 200 mg/dL (Ͻ5.2 mmol/L), and not smoking (among nondiabetic persons without history of myocardial infarction), show low-risk population rates of 6% in 1971 through 1975, 8% in 1976 through 1980, and 17% in both 1988 through 1994 and 1999 through 2000. 34 While genetic makeup undoubtedly influences the propensity to be at low risk, extensive data have shown that in populations with little or no CVD, adoption of adverse lifestyles results in increase of BMI, blood pressure, cholesterol level, and diagnosed diabetes. 35 Owing to advances in medicine and increases in life expectancy, higher proportions of persons with adverse risk factors earlier in life survive to experience their deleterious consequences in older age, including disease, disability, and higher health care costs. Our findings suggest that preventive measures at younger ages, that is, adherence to a healthy lifestyle, including a healthy diet, regular physical activity, and abstinence from smoking, can lead to a healthier older population with less disability and greater ability to function independently, hence potentially lowering costs for care at older ages, even in the year immediately preceding death. Not only do low-risk individuals have less disease and disability, [30] [31] [32] [33] our results suggest that they also experience lower acceleration in the functional decline common before death, which is reflected by their lower costs in the last year of life, lending further credence to the compression of morbidity hypothesis. 36 Few studies have linked health habits or CVD biomedical risk factors to health care costs among older persons, and in general risks were measured only a few years before costs were incurred. 37, 38 Nonsmoking, higher exercise level, and other healthy habits were associated with lower medical costs 37 ; elevated levels of cardiovascular risk factors (ie, systolic blood pressure, serum cholesterol level, and smoking) were related to higher annual Medicare costs. 38 A previous report on 13 796 CHA participants showed that total and CVD-and cancerrelated average annual Medicare charges over an 11-year period were much lower for persons with favorable risk status in middle age than for others (eg, for lowrisk men and women, total average annual Medicare charges were lower by $1615 and $1885; CVD-related charges lower by $979 and $556, respectively).
11 Recent findings on 2013 CHA participants (baseline ages 36-52 years) also suggest that compared with persons with 1 or more adverse risk factors, those without cardiovascular risk factors in middle age incurred lower cumulative Medicare expenditures from age 65 years to the point of death or to advanced ages, despite greater longevity. 39 Research on health care costs at the end of life has been limited mostly to the effects of sociodemographic factors (eg, age, sex, and race), 3, [12] [13] [14] various medical conditions, 14 or functional status and disability assessed mostly in the period just before death. 40 Among 261 decedents drawn from patients attending a fee-for-service group practice, total medical expenses in the last year of life did not differ greatly by functional status; hospital costs were lower, and nursing home and home health care costs were higher with 40 To our knowledge, the impact of risk status earlier in life on health care costs incurred in the last year of life has not been previously examined.
The current findings extend our previous report on health care costs 11 and demonstrate that CVD risk profile at younger ages also relates to Medicare expenditures in the year prior to death. Associations persisted when decedents with minor ECG abnormalities or diabetes at baseline were excluded and with adjustment for age at death, a major factor influencing end-of-life medical costs. 12, 13 Furthermore, the present study also includes BMI in the risk definition; this is of great public health importance because prevalence of overweight and obesity-a major independent CVD risk factor 41 -has increased markedly in the United States during the last few decades and continues to rise. 42, 43 For the CHA cohort, only 1 set of cardiovascular risk factor measurements was made, with no interim assessments of risk factors. Lack of repeat measures would likely lead to underestimation of the impact of baseline risk status, that is, bias results toward the null. Diet and physical activity were not assessed; therefore, it is not possible to determine the relation of these behaviors with end-of-life expenditures. Another limitation is lack of data on use of health services not covered by Medicare, most importantly, long-term nursing home care and prescription drugs. Among CHA participants 65 and older, adverse levels of cardiovascular risk factors measured earlier in life were associated with lower mental, social, and physical functioning in older age and higher use of prescription drugs. 30 Thus, potential bias from this limitation is likely to be toward underestimation of health care costs of unfavorable risk factors levels. Data on out-of-pocket payments are not included either; however, these constitute only a small proportion of total expenditures. In addition, Medicare data do not capture expenditures for decedents younger than 65 years. Nevertheless, the changing demographics of the US population (ie, increasing numbers of older persons) and the fact that most Americans (67%) die at 65 years or older 44 and that Medicare spends more than $220 billion per year in the health care of enrollees 45 warrants the study of costs incurred by older decedents. Finally, the use of only fee-for-service Medicare data may lead to underestimates of actual total health care expenditures because health care costs incurred outside the Medicare system are not accounted for. However, Medicare is the largest single source of health care spending in the United States, and exclusion of beneficiaries enrolled in managed care plans did not alter the observed positive relationship between risk profile and Medicare charges.
In conclusion, these data indicate that persons with favorable levels of all major cardiovascular risk factors in young adulthood or middle age have lower health care costs in the last year of life. Among those with unfavorable risk factors, the fewer the risk factors, the lower the Medicare expenditures in the year before death. Current treatments (including drug treatment and lifestyle modifications) to control adverse levels of cardiovascular risk factors, while effective, do not typically reduce morbidity and mortality to levels observed in low-risk individuals. 46, 47 Our findings underscore the importance of a comprehensive national public health policy emphasizing concurrent primary prevention of all major cardiovascular risk factors from early life on as an important strategic priority for controlling health care costs in older ages and at the end of life. 
